瘤治疗领域的进展和当前趋势:科学计量分析
Yang Xing1, Feroza Yasinjan1, Jiayue Cui2
1Department of Neurosurgery, The First Hospital of Jilin University.
International journal of surgery (London, England)
|February 13, 2024
概括
瘤治疗场 (TTFields) 疗法是一种非侵入性癌症治疗方法,研究兴趣日益增加. 科学度分析显示,TTFields的研究重点是临床应用和抗瘤机制,主要是针对质母细胞瘤.
科学领域:
- 在瘤学瘤学.
- 生物物理学的生物物理.
- 医疗技术 医疗技术 医学技术
背景情况:
- 瘤治疗场 (TTFields) 疗法是一种经批准的,非侵入性的癌症治疗方法,用于质母细胞瘤和恶性多层间皮瘤.
- 由于其已证明的疗效,TTFields疗法已经获得了大量的研究关注.
- 该领域的特点是正在进行的临床试验和临床前研究.
研究的目的:
- 为了对TTFields的研究进行科学测量分析.
- 确定出版趋势,领先的国家/机构和关键研究领域.
- 绘制当前的研究格局和TTFields治疗中的新兴热门话题.
主要方法:
- 对出版物数据的科学度分析.
- 随着时间的推移,对出版物和引用趋势的分析.
- 绘制国家,机构,作者,期刊和参考资料的地图.
- 关键词分析以确定研究主题.
主要成果:
- 出版人数仍然高且稳定,引文数量显著增加.
- 美国和以色列在出版物方面处于领先地位,其次是德国和瑞士.
- 研究主要集中在临床应用和抗瘤机制上.
- 质母细胞瘤是临床试验的主要焦点,其他癌症也在调查中.
结论:
- TTFields疗法是一个快速增长的研究领域,其全球影响力越来越大.
- 目前的研究分为临床应用和理解潜在的抗瘤机制.
- 未来的研究方向可能包括将TTFields的应用扩展到除质母细胞瘤之外的其他癌症类型.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


